Literature DB >> 591626

Metoclopramide increases plasma aldosterone concentration in man.

G Norbiato, M Bevilacqua, U Raggi, P Micossi, C Moroni.   

Abstract

Plasma Aldosterone (PA) response to metoclopramide (10 mg i.v.) was studied in 11 normal, 2 hypophysectomized subjects and in one patient with bilateral adrenal hyperplasia. All the subjects were kept on a normal sodium and potassium intake. Four normal subjects were pretreated with 1 mg of dexamethasone in order to inhibit endogenous ACTH. In all subjects metoclopramide elicited a prompt rise of PA comparable to that obtained with angiotensions or ACTH. No significant change of blood pressure, serum electrolytes, plasma renin activity, Plasma Cortisol (PC) was detected. The lack of PC response to metoclopramide and the PA increase in dexamethasone pretreated subjects rule out an ACTH mediated effect. The increase of PA in hypophysectomized subjects, in whom metoclopramide did not stimulate any prolactin release, rules out a prolactin mediated effect. Metoclopramide increases plasma aldosterone concentration probably via a direct action on the adrenal glomerular zone or throught another unknown mechanism.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 591626     DOI: 10.1210/jcem-45-6-1313

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  19 in total

1.  Aldosterone response to metoclopramide is mediated through the autonomic nervous system in man.

Authors:  D K Sommers; E C Meyer; M van Wyk; L S de Villiers
Journal:  Eur J Clin Pharmacol       Date:  1988       Impact factor: 2.953

2.  A serotonergic mechanism for the metoclopramide-induced increase in aldosterone level?

Authors:  C A Rizzi
Journal:  Eur J Clin Pharmacol       Date:  1994       Impact factor: 2.953

3.  Primary tissue culture of human adrenocortical Conn's adenomata. Bromocriptine as a possible agonist-antagonist of angiotensin at the cellular level.

Authors:  U Armato; F Mantero
Journal:  Cell Tissue Res       Date:  1984       Impact factor: 5.249

4.  Role of dopamine in the regulation of aldosterone and 18-hydroxycorticosterone secretion in man.

Authors:  J R Sowers; F W Beck
Journal:  J Endocrinol Invest       Date:  1984-10       Impact factor: 4.256

5.  Circadian variation in plasma dopamine levels in man.

Authors:  J R Sowers; N Vlachakis
Journal:  J Endocrinol Invest       Date:  1984-08       Impact factor: 4.256

6.  Clinical and biochemical features of patients with aldosterone-producing adenoma and idiopathic hyperaldosteronism.

Authors:  H Witzgall; O A Müller; P C Weber
Journal:  Klin Wochenschr       Date:  1983-01-03

7.  Metoclopramide, domperidone and dopamine in man: actions and interactions.

Authors:  T M MacDonald
Journal:  Eur J Clin Pharmacol       Date:  1991       Impact factor: 2.953

8.  In vitro steroidogenic properties of FK 33 824, a stable analog of methionine-enkephalin. Opiate-dopamine interaction in the control of aldosterone production.

Authors:  M Bevilacqua; T Vago; U Raggi; D Scorza; M Proverbio; E Malacco; G Norbiato
Journal:  J Endocrinol Invest       Date:  1982 Sep-Oct       Impact factor: 4.256

9.  Lack of prolactin involvement in corticosteroid secretion.

Authors:  J N Hugues; E Modigliani; F Girard; J Sebaoun
Journal:  J Endocrinol Invest       Date:  1987-02       Impact factor: 4.256

10.  Dopamine inhibits angiotensin-stimulated aldosterone biosynthesis in bovine adrenal cells.

Authors:  T J McKenna; D P Island; W E Nicholson; G W Liddle
Journal:  J Clin Invest       Date:  1979-07       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.